Update shared on16 Aug 2025
Fair value Increased 5.48%The upward revision in CRISIL's consensus analyst price target is primarily supported by marginal improvements in both forecast revenue growth and future P/E, raising the fair value estimate from ₹4,670 to ₹4,926.
What's in the News
- CRISIL's board approved the closure of Coalition Development Singapore, a wholly owned subsidiary, to streamline its global entity structure within 12 months.
- The board declared a second interim dividend of INR 9 per equity share for FY2025, payable on August 8, 2025.
- Board meetings were held to review and approve unaudited Q2 2025 financial results and consider the second interim dividend.
- A special shareholders meeting was called via postal ballot to consider the re-appointment of Ms. Shyamala Gopinath as an Independent Director.
Valuation Changes
Summary of Valuation Changes for CRISIL
- The Consensus Analyst Price Target has risen from ₹4670 to ₹4926.
- The Future P/E for CRISIL has risen slightly from 47.41x to 49.48x.
- The Consensus Revenue Growth forecasts for CRISIL has risen slightly from 10.9% per annum to 11.2% per annum.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.